Plasma beta-endorphin and beta-lipotropin in congestive heart failure in man. 1990

E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
Istituto di Scienze Biomediche Bassini, Università di Milano, Italy.

Beta-endorphin and beta-lipotropin plasma concentrations were evaluated in 24 patients with congestive heart failure (CHF) (10 patients had chronic CHF and 14 an acute episode superimposing on chronic CHF), and in 35 age matched controls. Beta-endorphin and beta-lipotropin were significantly lower (P less than 0.005 and P less than 0.001 respectively) in patients with CHF than in controls. A significant decrease of both peptides vs controls was observed also in the two subgroups of patients, with chronic and acute CHF, without statistical differences between the subgroups. Beta-endorphin and beta-lipotropin showed a close and significant correlation (r = 0.88, P less than 0.001) amongst the whole series of patients as well as in both subgroups with chronic and acute CHF. In consideration of the long duration of the disease the decreased concentrations of beta-endorphin and beta-lipotropin can be considered to be due to a depletion of the releasable pool of the peptides, as it was previously shown for chronic stress.

UI MeSH Term Description Entries
D008083 beta-Lipotropin A 90-amino acid peptide derived from post-translational processing of pro-opiomelanocortin (POMC) in the PITUITARY GLAND and the HYPOTHALAMUS. It is the C-terminal fragment of POMC with lipid-mobilizing activities, such as LIPOLYSIS and steroidogenesis. Depending on the species and the tissue sites, beta-LPH may be further processed to yield active peptides including GAMMA-LIPOTROPIN; BETA-MSH; and ENDORPHINS. Lipotropin,Adipozin,beta-LPH,beta-Lipotrophin,beta LPH,beta Lipotrophin,beta Lipotropin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D001615 beta-Endorphin A 31-amino acid peptide that is the C-terminal fragment of BETA-LIPOTROPIN. It acts on OPIOID RECEPTORS and is an analgesic. Its first four amino acids at the N-terminal are identical to the tetrapeptide sequence of METHIONINE ENKEPHALIN and LEUCINE ENKEPHALIN. Endorphin, beta,beta-Endorphin (1-31),beta Endorphin

Related Publications

E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
July 1991, Journal of the American College of Cardiology,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
January 1991, Journal of the American College of Cardiology,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
January 1997, Chest,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
September 1983, The Tohoku journal of experimental medicine,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
April 1987, European journal of obstetrics, gynecology, and reproductive biology,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
January 1986, Clinical neuropharmacology,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
December 1984, Life sciences,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
January 1970, The Medical journal of Australia,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
August 1984, Journal of applied physiology: respiratory, environmental and exercise physiology,
E Vitolo, and D Castini, and A Colombo, and P Collini, and D Gueli Alletti, and M Bianchi, and A E Panerai
September 1983, Masui. The Japanese journal of anesthesiology,
Copied contents to your clipboard!